TRANSFORMATIONAL MEDICINES THAT MAKE A DIFFERENCE
Dead / Abandoned — Abandoned — express abandonment (as of 15 May 2024)
What this means for you
This application is over — abandoned 06 May 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97931495
- Mark type
- Stylized text
- Filed
- 11 May 2023
- Abandoned
- 06 May 2024
- Attorney of record
- Beth H. Alter
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, medical and veterinary pharmaceutical preparations for the treatment of human and animal diseases of the autonomic, respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use; diagnostic preparations and materials, namely, diagnostic agents, preparations and substances for medical, pharmaceutical and veterinary purposes; disinfectants and antiseptics; medical dressings, coverings and applicators, namely, bandages for dressings, gauze for dressings, dressings for wounds, burns and surgery, cotton and synthetic swabs for medical use, adhesive plasters for medical use, inhalers filled with pharmaceutical products for the treatment of autonomic, respiratory diseases and disorders; natural remedies, namely, natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances and sleep disorders, and for the treatment of human diseases and disorders of the autonomic, respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; natural dietary supplements for the treatment of human diseases and disorders of the autonomic, respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical products for treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of ocular and dermatological diseases and disorders; pharmaceutical preparations and substances for the treatment of bacterial and viral infections, namely, anti-infectives
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, analysis, design and testing, in the field of pharmaceuticals and medicine; medical and pharmacological research services in the field of pharmaceuticals and medicine; natural science services, namely, scientific research, analysis, design and testing in the field of natural medicine and natural remedies; testing, namely, testing of pharmaceuticals and providing medical testing services in the field of research into human diseases of the autonomic, respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; authentication, namely, authentication of pharmaceutical and medicines; quality control for others; scientific investigation for medical purposes; bacteriological, chemical and biological investigation being scientific investigation for medical purposes
Owner
- Theravance Biopharma R&D IP, LLC, South San Francisco, CA
Prosecution history
- 15 May 2024 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
- 15 May 2024 — ABANDONMENT - EXPRESS MAILED
- 14 May 2024 — ASSIGNED TO EXAMINER
- 14 May 2024 — ASSIGNED TO EXAMINER
- 06 May 2024 — TEAS EXPRESS ABANDONMENT RECEIVED
- 06 Feb 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Feb 2024 — NON-FINAL ACTION E-MAILED
- 06 Feb 2024 — NON-FINAL ACTION WRITTEN
- 06 Feb 2024 — ASSIGNED TO EXAMINER
- 10 Jun 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 May 2023 — NEW APPLICATION ENTERED